Edition:
United States

ReNeuron Group PLC (RQE.L)

RQE.L on London Stock Exchange

2.55GBp
3:14am EST
Change (% chg)

0.00p (+0.00%)
Prev Close
2.62p
Open
2.62p
Day's High
--
Day's Low
--
Volume
487,212
Avg. Vol
--
52-wk High
--
52-wk Low
--

RQE.L

Chart for RQE.L

About

ReNeuron Group plc is a clinical-stage company. The Company, through its subsidiaries, is engaged in researching and developing cell-based therapies. The Company's products are allogeneic. Its CTX stem cell therapy is used for the treatment of patients left disabled by the effects of a stroke. Its human retinal progenitor cells... (more)

Overall

Beta: 0.96
Market Cap(Mil.): £83.07
Shares Outstanding(Mil.): 3,164.62
Dividend: --
Yield (%): --

Financials

  RQE.L Industry Sector
P/E (TTM): -- 46.47 30.92
EPS (TTM): -0.00 -- --
ROI: -21.57 -0.87 14.82
ROE: -21.67 -0.56 16.24

Earnings vs. Estimates